Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2005
CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's diseaseRichard Dubinsky, Carolyn Gray
Molecular and Biochemical Parasitology|May 14, 2003
ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flowCarolyn Gray, Christopher McCormick, Gareth Turner, et al.
American Journal of Medical Genetics. Part A|September 11, 2010
Mild phenotype in a patient with mosaic del(8p)/inv dup del(8p)Matthew Hand, Carolyn Gray, Gwen Glew, et al.
The Canadian Journal of Hospital Pharmacy|November 10, 2016
High-Dose, Extended-Interval Gentamicin and Tobramycin for Pediatric Inpatients: A Survey of Canadian Hospital PharmacistsCaitlin Roy, Carolyn Gray, Lisa Ruda, et al.
Journal of Clinical and Translational Science|September 2, 2025
Approaches and tools to measure individual-level research experience, activities, and outcomes: A narrative reviewBrenda M Joly, Carolyn Gray, Julia Rand, et al.
Molecular Microbiology|February 7, 2004
Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolatesMan Tsuey Tse, Kausik Chakrabarti, Carolyn Gray, et al.
Journal of Clinical and Translational Science|September 2, 2025
The development, validity, and reliability of the Researcher Investment ToolBrenda M Joly, Carolyn Gray, Kassandra Cousineau, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 2